It is known that SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) as a receptor to enter the host cells and a recent article reports that ACE2 levels are upregulated in AD brains (49). This evidence concerns the gene ACE2 and Alzheimer disease.